Safety and Efficacy of Allogeneic Hematopoetic Stem Cell Transplant (HSCT) after Treatment with Programmed Cell Death 1 (PD-1) Inhibitors

被引：0
作者：
Merryman, Reid W. [1 ]
Kim, Haesook T. [2 ]
Zinzani, Pier Luigi [3 ]
Carlo-Stella, Carmelo [4 ]
Ansell, Stephen M. [5 ]
Halwani, Ahmad S. [6 ]
Perales, Miguel-Angel [7 ]
Ho, Vincent T. [8 ]
Antin, Joseph H. [8 ]
Ritz, Jerome [9 ]
Soiffer, Robert J. [8 ]
Armand, Philippe [10 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[3] Univ Bologna, Inst Hematol L&A Seragnoli, Bologna, Italy
[4] Humanitas Clin & Res Ctr, Milan, Italy
[5] Mayo Clin, Rochester, MN USA
[6] Huntsman Canc Inst, Salt Lake City, UT USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
[8] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[9] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [22] Outcomes in Patients with Interstitial Lung Disease Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors
    Dobre, I.
    Frank, A. J.
    D'Silva, K. M.
    Okin, D.
    Sharma, A.
    Montesi, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Matsuda, Kotaro
    Miyoshi, Hiroaki
    Hiraoka, Koji
    Hamada, Tetsuya
    Yoshida, Shiro
    Ishibashi, Yukinao
    Haraguchi, Toshiaki
    Shiba, Naoto
    Ohshima, Koichi
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
  • [24] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Kotaro Matsuda
    Hiroaki Miyoshi
    Koji Hiraoka
    Tetsuya Hamada
    Shiro Yoshida
    Yukinao Ishibashi
    Toshiaki Haraguchi
    Naoto Shiba
    Koichi Ohshima
    Clinical and Experimental Medicine, 2018, 18 : 487 - 494
  • [25] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma
    Tamura, A.
    Yoshida, M.
    Yamamoto, N.
    Nakamura, S.
    Fujiwara, T.
    Tahara, T.
    Saito, A.
    Kozaki, A.
    Kishimoto, K.
    Ishida, T.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
  • [26] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [27] Safety and clinical efficacy of programmed cell death 1 antibodies (PD-1 Ab) in patients with advanced non-small cell lung cancer (NSCLC).
    Ksienski, Doran
    Wai, Elaine
    Croteau, Nicole
    Lesperance, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [28] PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation
    Jain, Prachi
    Tian, Xin
    Chen, Jinguo
    Cantilena, Caroline R.
    Bradley, Christian
    Panjwani, Reema
    Keyvanfar, Keyvan
    Chinian, Fariba
    Koklanaris, Eleftheria
    Superata, Jeanine
    Hauffe, Sara
    Battiwalla, Minoo
    Barrett, A. John
    Ito, Sawa
    BLOOD, 2017, 130
  • [29] Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group
    Sachie Kasai
    Hidehiro Itonaga
    Daisuke Niino
    Hiroaki Miyoshi
    Takeharu Kato
    Daisuke Imanishi
    Machiko Fujioka
    Takafumi Furumoto
    Shinya Sato
    Yasushi Sawayama
    Jun Taguchi
    Yoshitaka Imaizumi
    Tomoko Hata
    Shinichiro Yoshida
    Yukiyoshi Moriuchi
    Koichi Ohshima
    Yasushi Miyazaki
    International Journal of Hematology, 2020, 112 : 524 - 534
  • [30] Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group
    Kasai, Sachie
    Itonaga, Hidehiro
    Niino, Daisuke
    Miyoshi, Hiroaki
    Kato, Takeharu
    Imanishi, Daisuke
    Fujioka, Machiko
    Furumoto, Takafumi
    Sato, Shinya
    Sawayama, Yasushi
    Taguchi, Jun
    Imaizumi, Yoshitaka
    Hata, Tomoko
    Yoshida, Shinichiro
    Moriuchi, Yukiyoshi
    Ohshima, Koichi
    Miyazaki, Yasushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (04) : 524 - 534
12345